^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    gen-TRU-breast™ Assay

    Company:
    IV BioHoldings
    Type:
    Laboratory Developed Test
    Related tests:
    Details
    Evidence

    News

    1year
    Mammogen to showcase new data at SABCS 2023 demonstrating clinical efficacy of its genTRU-breast™ qPCR blood test in early-stage breast cancer (BioSpace)
    "Mammogen...is set to present groundbreaking clinical data at the 2023 San Antonio Breast Cancer Symposium (SABCS). The poster, titled 'Development of a plasma-based real-time qPCR gene expression assay for targeted screening and diagnosis of early-stage breast cancer,' showcases the strength and innovation of Mammogen's proprietary genTRU-breast clinical assay."
    Clinical data
    |
    gen-TRU-breast™ Assay
    1year
    Mammogen achieves CLIA validation of gen-TRU-breast™ Assay (PRNewswire)
    "Mammogen...has announced the successful completion of Clinical Laboratory Improvement Amendments (CLIA) validation for its pioneering plasma-based clinical assay, genTRU-breast, a test designed to detect the earliest stages of breast cancer. This achievement represents a momentous step forward in revolutionizing breast health."
    Regulatory
    |
    gen-TRU-breast™ Assay